Skip to content
Use caution Drug recall · FDA · Published November 25, 2019

Apothecus VCF Vaginal Contraceptive Foam Recall: Propellant Leakage Risk

Apothecus Pharmaceutical Corp. recalls VCF Vaginal Contraceptive Foam due to propellant leakage causing product and canister unusability. Affected units have specific NDC numbers and expiration dates.

🇺🇸 FDA recall #D-0623-2020DrugApothecus ›
Take action

Contact the company

Recalling firmApothecus Pharmaceutical Corp.485 S Broadway Ste 27 · Hicksville, NY 11801-5071
✎ GovInfoNow plain-language explainer

Apothecus Pharmaceutical Corp. is recalling VCF Vaginal Contraceptive Foam because the canister may leak propellant, making the product and container unusable. This could lead to ineffective contraception if used. Read more at govinfonow.com/recall/37671-apothecus-vcf-vaginal-contraceptive-foam-recall-propellant-leakage-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37671-apothecus-vcf-vaginal-contraceptive-foam-recall-propellant-leakage-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0623-2020

Cite this page

“Apothecus VCF Vaginal Contraceptive Foam Recall: Propellant Leakage Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37671-apothecus-vcf-vaginal-contraceptive-foam-recall-propellant-leakage-risk. Based on FDA recall #D-0623-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0623-2020%22&limit=1).

The FDA announced on 2019-11-25 that Apothecus Pharmaceutical Corp. recalled VCF Vaginal Contraceptive Foam due to a defective delivery system causing propellant leakage. The agency stated the product is unusable. This recall was voluntary and initiated by the firm.

How to tell if you have it

  • Brand: Apothecus
  • Product: VCF Vaginal Contraceptive Foam
  • NDC 52925-312-14 (can, 13 applications)
  • NDC 52925-312-06 (case pack)
  • Lot # 31560, 31561
  • Expiration date: 06/2021

The hazard

The recall addresses a defective delivery system where the canister unit exhibits propellant leakage or loss. This defect renders the product and canister unusable for consumers.

Context

GovInfoNow's records show Apothecus Pharmaceutical Corp. has 2 other recalls on record since 2024-03-21, including a 2024-11-22 recall for CGMP deviations and a 2024-03-21 recall for cGMP deviations. Other recent recalls of similar products include Teva Testosterone Gel 1% Risk of Leakage (2025-11-07), Keystone Safco SensiCaine-Ultra Gel Recall: Defective Container Risk (2026-05-21), and Keystone Dental City Topical Anesthetic Gel Recall: Defective Container Risk (2026-05-21).

How to tell if you have this one

Check for the NDC numbers 52925-312-14 (for single cans) or 52925-312-06 (for case packs). The product was distributed with expiration dates of 06/2021.

  • Brand
    Apothecus
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC numbers 52925-312-14 or 52925-312-06 on the can or case pack.

  2. Return or Discard

    Contact Apothecus Pharmaceutical Corp. to return the product or discard it safely.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the US and Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 4.8 years after the firm started it.

1. Firm started the recall: Nov 25, 201912. FDA classified it Class III: Dec 19, 201923. Published in FDA’s Enforcement Report: Dec 25, 201934. FDA terminated the recall: Sep 24, 2024420192024
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0623-2020 (November 25, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0623-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA